CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc 's Quick Ratio

ORMP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




ORMP Quick Ratio (May 31 2020)
III. Quarter
(Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
Y / Y Current Liabilities Change 63.27 % 113.37 % 51.5 % 16.58 % -55.42 %
Y / Y Cash & cash equivalent Change 55.89 % 0.96 % 4.18 % 5.97 % 12.07 %
Quick Ratio MRQ 9.95 5.65 6.56 6.08 10.42
Overall Ranking # # # # #
Seq. Current Liabilities Change -19.91 % 11.49 % -13.43 % 111.22 % 4.66 %
Seq. Cash & cash equivalent Change 41.16 % -4.01 % -6.66 % 23.24 % -8.58 %



Quick Ratio third quarter 2020 Comment
Oramed Pharmaceuticals Inc 's Cash & cash equivalent grew by 41.16 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Oramed Pharmaceuticals Inc 's Quick Ratio to 9.95, Quick Ratio remained below Oramed Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest Quick Ratio than Oramed Pharmaceuticals Inc in third quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ORMP Segments?
See Quick Ratio ORMP on the trailing twelve month basis
Quick Ratio third quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Overall Market # 7


Quick Ratio Statistics
High Average Low
66.8 13.72 3.7
(Feb 28 2014)   (Nov 30 2017)




Financial Statements
Oramed Pharmaceuticals Inc 's Current Liabilities $ 4 Millions Visit ORMP's Balance sheet
Oramed Pharmaceuticals Inc 's Cash & cash equivalent $ 41 Millions Visit ORMP's Balance sheet
Source of ORMP's Sales Visit ORMP's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMay 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioMay 31 2020 MRQ Cash & cash equivalentMay 31 2020 MRQ Current Liabilities
Restorbio Inc   19.89 $ 70.889  Millions$ 3.564  Millions
Uniqure N v   17.27 $ 314.265  Millions$ 18.192  Millions
Glycomimetics Inc   15.45 $ 149.897  Millions$ 9.701  Millions
Seres Therapeutics Inc   15.36 $ 63.940  Millions$ 4.163  Millions
Apellis Pharmaceuticals inc   15.05 $ 832.824  Millions$ 55.326  Millions
Agios Pharmaceuticals Inc   13.77 $ 790.128  Millions$ 57.372  Millions
Aravive Inc   13.25 $ 60.062  Millions$ 4.532  Millions
Oramed Pharmaceuticals Inc   9.95 $ 40.833  Millions$ 4.103  Millions
Aduro Biotech Inc   8.43 $ 171.131  Millions$ 20.303  Millions
United Therapeutics Corporation  8.04 $ 1,560.700  Millions$ 194.000  Millions
Aimmune Therapeutics Inc   7.73 $ 313.953  Millions$ 40.602  Millions
Retrophin Inc   7.39 $ 457.376  Millions$ 61.933  Millions
Immunic Inc   6.33 $ 48.607  Millions$ 7.674  Millions
Corvus Pharmaceuticals Inc   5.13 $ 59.258  Millions$ 11.553  Millions
Blueprint Medicines Corporation  4.97 $ 521.798  Millions$ 105.086  Millions
Minerva Neurosciences inc   4.76 $ 35.248  Millions$ 7.403  Millions
Macrogenics Inc   4.28 $ 196.532  Millions$ 45.894  Millions
Ultragenyx Pharmaceutical Inc   3.70 $ 813.416  Millions$ 219.729  Millions
Cyclerion Therapeutics Inc   3.61 $ 56.462  Millions$ 15.645  Millions
Vertex Pharmaceuticals Inc  3.03 $ 5,450.769  Millions$ 1,798.640  Millions
Alexion Pharmaceuticals Inc   2.55 $ 2,851.800  Millions$ 1,120.100  Millions
Ampio Pharmaceuticals inc   2.14 $ 4.842  Millions$ 2.267  Millions
Lexicon Pharmaceuticals Inc   2.07 $ 201.866  Millions$ 97.558  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FCBP's Profile

Stock Price

FCBP's Financials

Business Description

Fundamentals

Charts & Quotes

FCBP's News

Suppliers

FCBP's Competitors

Customers & Markets

Economic Indicators

FCBP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071